Heart Disease News and Research

Latest Heart Disease News and Research

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

19 Nov 2013

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Patients with acute coronary syndrome who were treated with the experimental drug varespladib were more likely to experience additional cardiovascular events - including sudden death, heart attack and stroke - than those treated with placebo, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

19 Nov 2013

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown.

19 Nov 2013

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

The National Basketball Association, Women's National Basketball Association, Africare and ExxonMobil today announced the launch of "Power Forward," a youth engagement initiative that will use basketball to develop health, leadership and life skills in Nigeria.

19 Nov 2013

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

Internationally recognised stem cell scientist, Associate ProfessorIgor Slukvin, University of Wisconsin – Madison, is visiting Australia as the key-note speaker at a Stem Cell Meeting and Workshop in Sydney next week.

19 Nov 2013

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with a sometimes deadly cost when taken for long periods: an increased risk for sudden cardiac death.

19 Nov 2013

Annual rates of CPR training vary widely across the U.S.

Annual rates of CPR training in the United States are low and vary widely across the country, but the communities most in need of training are the least likely to be trained, according to a new study from the Duke Clinical Research Institute.

19 Nov 2013

Researchers discover association between RDW levels and depression in heart disease patients

Researchers at the Intermountain Medical Center Heart Institute have discovered a link between elevated red cell distribution width levels and depression in patients being treated for heart disease.

19 Nov 2013

Preschoolers can learn about healthy eating and exercise through Sesame Street

In a study presented on November 18 at the American Heart Association's Scientific Sessions 2013, preschoolers in Bogotá, Colombia participating in a structured curriculum that used Sesame Street's Healthy Habits for Life materials improved their knowledge, attitudes and habits related to a heart-healthy lifestyle. Also, the percentage of children at a healthy weight improved by 13 percent.

19 Nov 2013

Study: Use of bone marrow mononuclear stem cells does not improve heart function

New data reported by the Cardiovascular Cell Therapy Research Network (CCTRN) at the 2013 Scientific Sessions of the American Heart Association in Dallas showed that the use of bone marrow mononuclear stem cells (BMCs) did not improve heart function significantly more at one year than at six months.

19 Nov 2013

$Faster surgery after hip fracture may be better for older patients, say researchers$

Faster surgery after hip fracture may be better for older patients, say researchers

The speed of surgery after a hip fracture may have a significant impact on outcomes for older patients, and faster may be better, say researchers at McMaster University.

19 Nov 2013

Study examines two surgical approaches for treatment of severe ischemic mitral regurgitation

The Cardiothoracic Surgical Trials Network, whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation -- mitral valve repair and mitral valve replacement.

19 Nov 2013

Researchers determine link of CAC volume and CAC density with cardiovascular disease

Michael H. Criqui, M.D., M.P.H., of the University of California, San Diego, and colleagues determined the independent associations of coronary artery calcium (CAC) volume and CAC density with cardiovascular disease events.

19 Nov 2013

TOPCAT trial results of spironolactone presented at AHA Scientific Sessions

A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.

19 Nov 2013

Two drugs tested in larger trial fail to improve kidney function in patients with acute heart failure

Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association's Scientific Sessions 2013 in Dallas and simultaneously published in the Journal of the American Medical Association. Previous smaller studies showed that low-dose dopamine or low-dose nesiritide could improve kidney function and reduce fluid overload that is often present in hospitalized acute heart failure patients by increasing urine production.

19 Nov 2013

Cranberries' unique bioactive compounds improve heart health and temper inflammation

Cranberries are more than a holiday favorite, given their remarkable nutritional and health benefits. A new research review published in the international journal Advances in Nutrition provides reasons why these tiny berries can be front and center and not just a side dish. The review authors conclude that cranberries provide unique bioactive compounds that may help reduce the incidence of certain infections, improve heart health and temper inflammation.

19 Nov 2013

Viewpoints: Obamacare has resisted death throes before; website success stories from 3 governors; health law taking a toll on choice of doctors in Medicare Advantage

The first time Obamacare seemed finished, doomed, doornail-dead, the voters of Massachusetts played the would-be executioner. In January 2010, they sent a pickup-driving Republican to the Senate to fill Ted Kennedy's seat, apparently depriving the health care bill of its crucial 60th vote and sending Democrats scrambling for a Plan B. ... the deeper force at work, the reason that these near-death experiences keep happening, isn't a website or a broken presidential promise. It's a problem inherent to contemporary liberalism, which is that liberals' proudest achievement, the modern welfare state, tends to resist, corrupt and baffle their efforts at comprehensive reform (Ross Douthat, 11/16).

19 Nov 2013

Grave prognosis for heart patients with treatment-resistant hypertension

Patients with coronary artery disease have a particularly high risk for poor outcomes if they have treatment-resistant hypertension, shows an analysis of the Treating to New Targets trial.

18 Nov 2013

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

Paragonix Technologies, Inc. today announced that it has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its Paragonix Sherpa Pak Cardiac Transport System(CTS).

18 Nov 2013

Researchers create new hybrid heart valve that remains strong, durable throughout the tests

A hybrid heart valve created from thin and highly elastic mesh embedded within layers of human cells was strong and durable in a study presented at the American Heart Association's Scientific Sessions 2013.

18 Nov 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Annual rates of CPR training vary widely across the U.S.

Researchers discover association between RDW levels and depression in heart disease patients

Preschoolers can learn about healthy eating and exercise through Sesame Street

Study: Use of bone marrow mononuclear stem cells does not improve heart function

Faster surgery after hip fracture may be better for older patients, say researchers

Study examines two surgical approaches for treatment of severe ischemic mitral regurgitation

Researchers determine link of CAC volume and CAC density with cardiovascular disease

TOPCAT trial results of spironolactone presented at AHA Scientific Sessions

Two drugs tested in larger trial fail to improve kidney function in patients with acute heart failure

Cranberries' unique bioactive compounds improve heart health and temper inflammation

Viewpoints: Obamacare has resisted death throes before; website success stories from 3 governors; health law taking a toll on choice of doctors in Medicare Advantage

Grave prognosis for heart patients with treatment-resistant hypertension

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

Researchers create new hybrid heart valve that remains strong, durable throughout the tests

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in